North American Sleep-Wake Disorder Market
North American Sleep-Wake Disorder Market Size, Share & Trends Analysis By Disorder Type (Insomnia, Hypersomnia, Sleep Apnea, Circadian Rhythm Sleep-Wake Disorders, Parasomnias, Dyssomnias, and Others), By Treatment Type (Pharmacological Therapy, Behavioral Therapy, Light Therapy, Device-Based Therapy, and Others), By Diagnosis & Management Approach (Polysomnography & Sleep Studies, Actigraphy-Based Monitoring, Clinical Evaluation & Screening Tools, and Remote/Digital Sleep Monitoring Solutions), and By Application (Hospitals, Home Care Settings, and Others), Forecast Period (2026-2035)
Industry Overview
North American sleep-wake disorder market was valued at $8.3 billion in 2025 and is projected to reach $15.1 billion by 2035, growing at a CAGR of 6.1% from 2026 to 2035. The North American market continues to witness steady expansion, supported by increasing clinical attention toward long-term neurological and sleep-related health conditions. Greater availability of advanced diagnostic facilities and wider adoption of home-based monitoring technologies have strengthened patient access to treatment solutions across the region. In addition, favorable reimbursement frameworks and higher healthcare spending have encouraged the integration of innovative therapeutic approaches into routine care practices. Market growth is further supported by ongoing research activities, rising awareness regarding the impact of untreated sleep conditions, and the presence of established healthcare infrastructure across the United States and Canada.
Market Dynamics
Expansion of Home-Based Sleep Monitoring Technologies
The North American market is witnessing a notable shift toward home-based diagnostic and monitoring solutions for sleep-related conditions. Healthcare providers are increasingly adopting portable sleep testing systems and remote patient monitoring platforms to improve accessibility and reduce dependency on in-clinic evaluations. This trend is supported by growing patient preference for convenient diagnostic methods and the increasing integration of digital health technologies into routine care. Advancements in connected devices and cloud-based data management systems are also enabling more efficient long-term patient assessment. In addition, improved insurance coverage for home diagnostics has contributed to broader acceptance of these solutions across the region. The trend continues to support operational efficiency while enhancing patient engagement and treatment continuity.
Rising Adoption of Personalized Treatment Approaches
A growing emphasis on individualized treatment strategies is influencing the development of the North American market. Healthcare organizations are increasingly focusing on tailored therapeutic plans based on patient-specific sleep patterns, medical history, and coexisting health conditions. The use of data-driven clinical assessments and advanced analytics is supporting more precise treatment recommendations and improved patient outcomes. Pharmaceutical and medical device companies are also investing in targeted therapies and next-generation treatment technologies to address varying levels of disorder severity. Furthermore, collaboration between sleep clinics, technology providers, and research institutions is accelerating innovation within the regional healthcare ecosystem. This evolving approach is contributing to improved treatment adherence and long-term disease management across diverse patient populations.
Market Segmentation
- Based on the disorder type, the market is segmented into insomnia, hypersomnia, sleep apnea, circadian rhythm sleep-wake disorders, parasomnias, dyssomnias, and others.
- Based on the treatment type, the market is segmented into pharmacological therapy, behavioral therapy, light therapy, device-based therapy, and others.
- Based on the diagnosis & management approach, the market is segmented into polysomnography & sleep studies, actigraphy-based monitoring, clinical evaluation & screening tools, and remote/digital sleep monitoring solutions.
- Based on the application, the market is segmented into hospitals, home care settings, and others.
Sleep Apnea Segment to Lead the Market with the Largest Share
The sleep apnea segment continues to expand steadily due to increasing diagnosis rates and growing awareness regarding long-term cardiovascular and respiratory complications associated with untreated conditions. Demand for advanced airway pressure systems, implantable stimulation devices, and connected respiratory monitoring platforms has strengthened the competitive landscape across developed healthcare markets. Companies such as ResMed Inc., Inspire Medical Systems Inc., and Koninklijke Philips N.V. are focusing on product innovation and patient-friendly treatment technologies to improve therapy adherence. Recent industry activity has also highlighted the integration of artificial intelligence and cloud-based monitoring features into sleep management devices. In addition, rising preference for home-based testing solutions has accelerated early-stage identification and treatment initiation among adult patient populations. Healthcare providers are further expanding multidisciplinary sleep care programs to support long-term disease management and follow-up monitoring.
Remote/Digital Sleep Monitoring Solutions: A Key Segment in Market Growth
The remote/digital sleep monitoring solutions segment is gaining significant commercial traction as healthcare systems increasingly adopt virtual care models and connected diagnostic technologies. Wider use of wearable sensors, mobile health applications, and cloud-integrated monitoring platforms has improved the ability to track sleep patterns outside conventional clinical environments. Leading participants, including Nox Health Group Inc., Compumedics Limited, and Fisher and Paykel Healthcare Corporation Limited, are investing in digital platforms designed to support continuous patient engagement and remote data analysis. The segment is also benefiting from growing consumer interest in preventive health monitoring and personalized wellness management. Recent developments indicate stronger collaboration between technology providers and healthcare institutions to improve remote diagnostic accuracy and treatment efficiency. Expansion of telehealth infrastructure across North America and Europe is further supporting the adoption of digitally enabled sleep assessment solutions.
Regional Outlook
The North American sleep-wake disorder market is further divided by countries, including the US and Canada..
US Dominates the Market with Major Share
The US continues to represent a leading contributor to market expansion due to its advanced healthcare infrastructure, high diagnostic penetration, and broad availability of specialized sleep treatment centers. Increasing recognition of sleep-related disorders among working-age and elderly populations has supported consistent demand for therapeutic devices, prescription therapies, and digital monitoring systems. Major industry participants such as ResMed Inc., Inspire Medical Systems Inc., and Eli Lilly and Company are strengthening their presence through product innovation and clinical research initiatives. The market is also witnessing higher adoption of connected care platforms and home-based diagnostic services aimed at improving patient convenience and long-term treatment adherence. Recent trends indicate growing investment in artificial intelligence-enabled sleep analysis and remote patient monitoring technologies. In addition, favorable reimbursement frameworks and rising healthcare expenditure continue to support commercial expansion across the country.
Market Players Outlook
The major companies operating in the North American sleep-wake disorder market include ResMed Inc., Inspire Medical Systems Inc., Harmony Biosciences Holdings Inc., Eli Lilly and Company, and Jazz Pharmaceuticals plc., among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.
Recent Development
- In February 2026, Inspire Medical Systems Inc. confirmed the completion of the commercial rollout of its Inspire V neurostimulation platform for obstructive sleep apnea treatment in the United States. The company also announced FDA approval for 3.0T MRI compatibility, expanding patient eligibility and strengthening the clinical value of the implantable therapy system. The launch reflected increasing adoption of minimally invasive sleep apnea therapies in North America, particularly among patients unable to tolerate conventional CPAP devices. The expansion further demonstrated the company’s focus on technology upgrades and broader procedural adoption across sleep treatment centers.
- In April 2025, ResMed Inc. expanded its North American sleep diagnostics portfolio by commercially launching the NightOwl home sleep apnea testing solution across the United States. The FDA-cleared platform was introduced to simplify obstructive sleep apnea diagnosis through an at-home testing approach, reflecting the growing shift toward remote patient monitoring and decentralized sleep care. The launch strengthened the company’s position in digital sleep diagnostics while supporting faster diagnosis rates and improved patient accessibility. The development also aligned with increasing demand for connected care platforms and AI-enabled sleep management technologies in North America.
The Report Covers
- Market value data analysis for 2025 and forecast to 2035.
- Annualized market revenues ($ million) for each market segment.
- Country-wise analysis of major geographical regions.
- Key companies operating in the North American sleep-wake disorder market. Based on the availability of data, information related to new products and relevant news is also available in the report.
- Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
- Analysis of market-entry and market expansion strategies.
- Competitive strategies by identifying ‘who-stands-where’ in the market.
- Report Summary
- Current Industry Analysis and Growth Potential Outlook
- North American Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application ($ Million)
- Sleep-Wake Disorder Market Sales Performance of Top Countries
- Research Methodology
- Primary Research Approach
- Secondary Research Approach
- Market Snapshot
- Market Overview and Insights
- Scope of the Study
- Analyst Insight & Current Market Trends
- Key Sleep-Wake Disorder Industry Trends
- Market Recommendations
- Porter's Five Forces Analysis for the Sleep-Wake Disorder Market
- Competitive Rivalry
- Threat of New Entrants
- Bargaining Power of Suppliers
- Bargaining Power of Buyers
- Threat of Substitutes
- Market Determinants
- Market Drivers
- Drivers For North American Sleep-Wake Disorder Market: Impact Analysis
- Market Pain Points and Challenges
- Restraints For North American Sleep-Wake Disorder Market: Impact Analysis
- Market Opportunities
- Opportunities For North American Sleep-Wake Disorder Market: Impact Analysis
- Market Drivers
- Competitive Landscape
- Competitive Dashboard – Sleep-Wake Disorder Market Revenue and Share by Manufacturers
- Sleep-Wake Disorder Product Comparison Analysis
- Top Market Player Ranking Matrix
- Key Company Analysis
- Eli Lilly and Company
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Harmony Biosciences Holdings Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Inspire Medical Systems Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Jazz Pharmaceuticals plc
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- ResMed Inc.
- Overview
- Product Portfolio
- Financial Analysis
- SWOT Analysis
- Business Strategy
- Top Winning Strategies by Market Players
- Merger and Acquisition
- Product Launch
- Partnership and Collaboration
- Eli Lilly and Company
- Key Company Analysis
- North American Sleep-Wake Disorder Market Sales Analysis by Disorder Type ($ Million)
- Insomnia
- Hypersomnia
- Sleep Apnea
- Circadian Rhythm Sleep-Wake Disorders
- Parasomnias
- Dyssomnias
- Others
- North American Sleep-Wake Disorder Market Sales Analysis by Treatment Type ($ Million)
- Pharmacological Therapy
- Behavioral Therapy
- Light Therapy
- Device-Based Therapy
- Others
- North American Sleep-Wake Disorder Market Sales Analysis by Diagnosis & Management Approach ($ Million)
- Polysomnography & Sleep Studies
- Actigraphy-Based Monitoring
- Clinical Evaluation & Screening Tools
- Remote / Digital Sleep Monitoring Solutions
- North American Sleep-Wake Disorder Market Sales Analysis by Application ($ Million)
- Hospitals
- Home Care Settings
- Others
- Regional Analysis
- North American Sleep-Wake Disorder Market Sales Analysis – Disorder Type | Treatment Type | Diagnosis & Management Approach | Application | Country ($ Million)
- Macroeconomic Factors for North America
- United States
- Canada
- Company Profiles
- Apnimed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Axsome Therapeutics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- BMC Medical Co. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Cadwell Industries Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Compumedics Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Curative Medical Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Drive DeVilbiss Healthcare LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Eli Lilly and Company
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Fisher and Paykel Healthcare Corp. Ltd.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Harmony Biosciences Holdings Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Inspire Medical Systems Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Jazz Pharmaceuticals plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Koninklijke Philips N.V.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Medtronic plc
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Neurocrine Biosciences Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nihon Kohden Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Nox Health Group Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ProSomnus Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- React Health Holdings LLC
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- ResMed Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sleep Number Corp.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Sommetrics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Somnetics International Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vanda Pharmaceuticals Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Vivos Therapeutics Inc.
- Quick Facts
- Company Overview
- Product Portfolio
- Business Strategies
- Apnimed Inc.
1. North American Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
2. North American Insomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
3. North American Hypersomnia Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
4. North American Sleep Apnea Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
5. North American Circadian Rhythm Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
6. North American Parasomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
7. North American Dyssomnias Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
8. North American Other Sleep-Wake Disorder Market Research and Analysis by Region, 2025-2035 ($ Million)
9. North American Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
10. North American Sleep-Wake Disorder by Pharmacological Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
11. North American Sleep-Wake Disorder by Behavioral Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
12. North American Sleep-Wake Disorder by Light Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
13. North American Sleep-Wake Disorder by Device-Based Therapy Market Research and Analysis by Region, 2025-2035 ($ Million)
14. North American Sleep-Wake Disorder by Other Treatment Type Market Research and Analysis by Region, 2025-2035 ($ Million)
15. North American Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
16. North American Polysomnography & Sleep Studies Market Research and Analysis by Region, 2025-2035 ($ Million)
17. North American Actigraphy-Based Monitoring Market Research and Analysis by Region, 2025-2035 ($ Million)
18. North American Clinical Evaluation & Screening Tools Market Research and Analysis by Region, 2025-2035 ($ Million)
19. North American Remote / Digital Sleep Monitoring Solutions Market Research and Analysis by Region, 2025-2035 ($ Million)
20. North American Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
21. North American Sleep-Wake Disorder for Hospitals Market Research and Analysis by Region, 2025-2035 ($ Million)
22. North American Sleep-Wake Disorder for Home Care Settings Market Research and Analysis by Region, 2025-2035 ($ Million)
23. North American Sleep-Wake Disorder for Other Application Market Research and Analysis by Region, 2025-2035 ($ Million)
24. North American Sleep-Wake Disorder Market Research and Analysis by Geography, 2025-2035 ($ Million)
25. North American Sleep-Wake Disorder Market Research and Analysis by Country, 2025-2035 ($ Million)
26. North American Sleep-Wake Disorder Market Research and Analysis by Disorder Type, 2025-2035 ($ Million)
27. North American Sleep-Wake Disorder Market Research and Analysis by Treatment Type, 2025-2035 ($ Million)
28. North American Sleep-Wake Disorder Market Research and Analysis by Diagnosis & Management Approach, 2025-2035 ($ Million)
29. North American Sleep-Wake Disorder Market Research and Analysis by Application, 2025-2035 ($ Million)
1. North American Sleep-Wake Disorder Market Share by Disorder Type, 2025 Vs 2035 (%)
2. North American Insomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
3. North American Hypersomnia Disorder Market Share by Region, 2025 Vs 2035 (%)
4. North American Sleep Apnea Disorder Market Share by Region, 2025 Vs 2035 (%)
5. North American Circadian Rhythm Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
6. North American Parasomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
7. North American Dyssomnias Disorder Market Share by Region, 2025 Vs 2035 (%)
8. North American Other Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
9. North American Sleep-Wake Disorder Market Share by Treatment Type, 2025 Vs 2035 (%)
10. North American Sleep-Wake Disorder by Pharmacological Therapy Market Share by Region, 2025 Vs 2035 (%)
11. North American Sleep-Wake Disorder by Behavioral Therapy Market Share by Region, 2025 Vs 2035 (%)
12. North American Sleep-Wake Disorder by Light Therapy Market Share by Region, 2025 Vs 2035 (%)
13. North American Sleep-Wake Disorder by Device-Based Therapy Market Share by Region, 2025 Vs 2035 (%)
14. North American Sleep-Wake Disorder by Other Treatment Type Market Share by Region, 2025 Vs 2035 (%)
15. North American Sleep-Wake Disorder Market Share by Diagnosis & Management Approach, 2025 Vs 2035 (%)
16. North American Polysomnography & Sleep Studies Market Share by Region, 2025 Vs 2035 (%)
17. North American Actigraphy-Based Monitoring Market Share by Region, 2025 Vs 2035 (%)
18. North American Clinical Evaluation & Screening Tools Market Share by Region, 2025 Vs 2035 (%)
19. North American Remote / Digital Sleep Monitoring Solutions Market Share by Region, 2025 Vs 2035 (%)
20. North American Sleep-Wake Disorder Market Share by Application, 2025 Vs 2035 (%)
21. North American Sleep-Wake Disorder for Hospitals Market Share by Region, 2025 Vs 2035 (%)
22. North American Sleep-Wake Disorder for Home Care Settings Market Share by Region, 2025 Vs 2035 (%)
23. North American Sleep-Wake Disorder for Other Application Market Share by Region, 2025 Vs 2035 (%)
24. North American Sleep-Wake Disorder Market Share by Region, 2025 Vs 2035 (%)
25. US Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
26. Canada Sleep-Wake Disorder Market Size, 2025-2035 ($ Million)
- Printable version
- No restriction to number of users within the company
